Fcyriia transgenic animal model for autoimmune disease

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) C07K 14/735 (2006.01) C12N 15/85 (2006.01)

Patent

CA 2488775

The present invention provides a Fc.gamma.RIIa transgenic non-human animal model for autoimmune disease, particularly arthritis. This invention also provides a method of using this model to screen compounds that can reduce aberrant immune activity including aberrant immune complex formation aberrant immune complex clearance and immune complex induced inflammation. This invention also provides means of using this model to treat or prevent autoimmune disease.

La présente invention concerne un modèle animal transgénique de Fc.gamma.RIIa pour affection auto-immune, en particulier l'arthrite. L'invention concerne également un procédé d'utilisation de ce modèle pour la recherche systématique de composés qui peuvent réduire l'activité immune aberrante, y-compris la formation de complexes immunitaires aberrants, la clairance de complexes immunitaires aberrants, et l'inflammation induite par des complexes immunitaires. L'invention concerne aussi des moyens permettant d'utiliser ce modèle pour traiter ou prévenir une affection auto-immune.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fcyriia transgenic animal model for autoimmune disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fcyriia transgenic animal model for autoimmune disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fcyriia transgenic animal model for autoimmune disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2013785

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.